Literature DB >> 16126014

Do serological tissue turnover markers represent callus formation during fracture healing?

P Seebeck1, H J Bail, C Exner, H Schell, R Michel, H Amthauer, H Bragulla, G N Duda.   

Abstract

Serological parameters of bone and fibrous tissue turnover were demonstrated to monitor the course of fracture healing. The aim of this study was to evaluate the correlation between the serological parameter levels during fracture healing and callus development in a standardised ovine model of fracture healing. Two years old female sheep received a standardised 3 mm tibial bone defect stabilised by an external fixator. The serological levels of the C-terminal propeptide of procollagen type I (PICP), bone specific alkaline phosphatase (bALP), total alkaline phosphatase (tALP), osteocalcin, tartrate-resistant acid phosphatase (TRAP), calcium, phosphate and the N-terminal peptide of procollagen type III (PIIINP) were observed over a 9-week healing period. The course of fracture healing was monitored radiographically, and the callus composition was evaluated histologically at 2, 3, 6 and 9 weeks post-surgery. The serological results were compared with an untreated control group. Additionally, the maximum values during healing were compared with juvenile values to gauge the level of the serological response. The histological and radiographical results demonstrated callus formation without complications. All serological parameters showed broad inter-individual variations, and the response to the standardised fracture scenario was strongly individual. Maximum values during fracture healing did not reach the juvenile levels. The fractured as well as the control animals showed significant changes in the parameter levels. No correlations were observed between the histological course of healing and the course of bone formation markers whilst the TRAP level was reduced during bony callus formation. The PIIINP level increased when the amount of soft callus tissue decreased during healing. The observed bone formation markers were not suitable as general markers to detect the course of fracture healing, whilst PIIINP was able to reflect soft callus degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126014     DOI: 10.1016/j.bone.2005.06.008

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction.

Authors:  David S Sparks; Siamak Saifzadeh; Flavia Medeiros Savi; Constantin E Dlaska; Arne Berner; Jan Henkel; Johannes C Reichert; Martin Wullschleger; Jiongyu Ren; Amaia Cipitria; Jacqui A McGovern; Roland Steck; Michael Wagels; Maria Ann Woodruff; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Nat Protoc       Date:  2020-02-14       Impact factor: 13.491

2.  Bone turnover markers do not predict stress fracture in elite combat recruits.

Authors:  Ran Yanovich; Rachel K Evans; Eitan Friedman; Daniel S Moran
Journal:  Clin Orthop Relat Res       Date:  2012-12-13       Impact factor: 4.176

Review 3.  Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing.

Authors:  Marlon O Coulibaly; Debra L Sietsema; Travis A Burgers; Jim Mason; Bart O Williams; Clifford B Jones
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

4.  Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat.

Authors:  E K Stuermer; S Sehmisch; T Rack; E Wenda; D Seidlova-Wuttke; M Tezval; W Wuttke; K H Frosch; K M Stuermer
Journal:  Langenbecks Arch Surg       Date:  2008-12-02       Impact factor: 3.445

5.  Serum proteomic assessment of the progression of fracture healing.

Authors:  Amira I Hussein; Christian Mancini; Kyle E Lybrand; Margaret E Cooke; Heather E Matheny; Brenna L Hogue; Paul Tornetta; Louis C Gerstenfeld
Journal:  J Orthop Res       Date:  2017-11-22       Impact factor: 3.494

6.  Evaluation of a topical herbal agent for the promotion of bone healing.

Authors:  Wing-Sum Siu; Chun-Hay Ko; Ka-Wing Lam; Elaine Wat; Wai-Ting Shum; Clara Bik-San Lau; Kam-Ming Ko; Leung-Kim Hung; David Tai-Wai Lau; Ping-Chung Leung
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-25       Impact factor: 2.629

7.  Effects of "vitex agnus castus" extract and magnesium supplementation, alone and in combination, on osteogenic and angiogenic factors and fracture healing in women with long bone fracture.

Authors:  Mohammad Hassan Eftekhari; Zahra Hassanzadeh Rostami; Mohammad Jafar Emami; Hamid Reza Tabatabaee
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

8.  Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.

Authors:  Donatella Granchi; Enrique Gómez-Barrena; Markus Rojewski; Philippe Rosset; Pierre Layrolle; Benedetta Spazzoli; Davide Maria Donati; Gabriela Ciapetti
Journal:  Stem Cells Int       Date:  2017-06-20       Impact factor: 5.443

9.  Tartrate-resistant acid phosphate as biomarker of bone turnover over the lifespan and different physiologic stages in sheep.

Authors:  José A Camassa; Camila C Diogo; João P A Bordelo; Marília de A Bonelli; Carlos A Viegas; Jorge T Azevedo; Nuno Dourado; Isabel R Dias
Journal:  BMC Vet Res       Date:  2017-08-15       Impact factor: 2.741

Review 10.  Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.

Authors:  Byung-Ho Yoon; Woojin Yu
Journal:  J Bone Metab       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.